Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K. Verma, William H. Miller, Alan P. Graves et al.|ACS Medicinal Chemistry Letters|2012Cited by 377
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D. Knight, Dashyant Dhanak, Nicholas D. Adams et al.|ACS Medicinal Chemistry Letters|2010Cited by 374
Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C KinaseNicholas D. Adams, Dashyant Dhanak, Jerry L. Adams et al.|Journal of Medicinal Chemistry|2010Cited by 111
Abstract C62: Identification of GSK2126458, a highly potent inhibitor of phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR)Steven D. Knight, Dashyant Dhanak, Nicholas D. Adams et al.|Molecular Cancer Therapeutics|2009Cited by 4
Abstract 2939: Discovery and synthesis of highly potent and selective small molecule inhibitors of the histone methyltransferase EZH2Sharad K. Verma, Dash Dhanak, Louis V. LaFrance et al.|Cancer Research|2012Cited by 1